Volume 7, Issue 3 (2021)
IEM 2021, 7(3): 229-236 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zarimeidani R, Roudbar mohammadi S, Roudbary M, Nikoomanesh F, Aslani P, Yaalimadad S. In-Vitro Antifungal Activity of Nano Encapsulated Caprylic Acid and EFG1 Gene Expression Profile in Candida albicans. IEM 2021; 7 (3) :229-236
URL: http://iem.modares.ac.ir/article-4-51646-en.html
URL: http://iem.modares.ac.ir/article-4-51646-en.html
Reyhaneh Zarimeidani1 
, Shahla Roudbar mohammadi * 2, Maryam Roudbary3 , Fatemeh Nikoomanesh4 , Peyman Aslani5 , Sanaz Yaalimadad6
, Shahla Roudbar mohammadi * 2, Maryam Roudbary3 , Fatemeh Nikoomanesh4 , Peyman Aslani5 , Sanaz Yaalimadad6
1- Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
2- Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran ,sh.mohammadi@modares.ac.ir
3- Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
5- Department of Parasitology and Mycology, Faculty of Medicine, Aja University of Medical Sciences
6- Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran,Iran
2- Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran ,
3- Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
5- Department of Parasitology and Mycology, Faculty of Medicine, Aja University of Medical Sciences
6- Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran,Iran
Abstract: (1864 Views)
Backgrounds: Due to the emergence of multidrug-resistant Candida species, the discovery of new antifungal agents with minimum side effects is essential. The aim of this study was to investigate the antifungal activity of caprylic acid and nano-encapsulated caprylic acid against C. albicans as well as their effect on the expression of EFG1 gene.
Materials & Methods: In this laboratory trial study, the minimum inhibitory concentration (MIC) of caprylic acid and nano-encapsulated caprylic acid against C. albicans was evaluated at various concentrations (400-625 and 1.3-50 μL/mL, respectively). Real time-PCR was performed to assess the expression level of EFG1 gene. Cytotoxicity effect of caprylic acid and nano-encapsulated caprylic acid was evaluated on SW480 cell line using MTT test.
Findings: Antifungal activity findings displayed that MIC90 and MIC50 values of caprylic acid were 500 and 450 μg/mL, respectively, whereas MIC90 and MIC50 values of nano-encapsulated caprylic acid were 6.2 and 3.1 μg/mL, respectively. The expression of EFG1 gene significantly decreased in the groups treated with caprylic acid and nano-encapsulated caprylic acid compared to the control group. According to the cytotoxicity evaluation findings, the viability of cells treated with caprylic acid was significantly higher than that of cells exposed to nano-encapsulated caprylic acid.
Conclusions: According to the obtained results, nano-encapsulated caprylic acid successfully inhibited C. albicans growth at a lower concentration compared to caprylic acid. Overall, it was found that nano-encapsulated caprylic acid is a promising antifungal agent against Candida species; however, further studies are needed to be performed about nano-encapsulation of caprylic acid.
Materials & Methods: In this laboratory trial study, the minimum inhibitory concentration (MIC) of caprylic acid and nano-encapsulated caprylic acid against C. albicans was evaluated at various concentrations (400-625 and 1.3-50 μL/mL, respectively). Real time-PCR was performed to assess the expression level of EFG1 gene. Cytotoxicity effect of caprylic acid and nano-encapsulated caprylic acid was evaluated on SW480 cell line using MTT test.
Findings: Antifungal activity findings displayed that MIC90 and MIC50 values of caprylic acid were 500 and 450 μg/mL, respectively, whereas MIC90 and MIC50 values of nano-encapsulated caprylic acid were 6.2 and 3.1 μg/mL, respectively. The expression of EFG1 gene significantly decreased in the groups treated with caprylic acid and nano-encapsulated caprylic acid compared to the control group. According to the cytotoxicity evaluation findings, the viability of cells treated with caprylic acid was significantly higher than that of cells exposed to nano-encapsulated caprylic acid.
Conclusions: According to the obtained results, nano-encapsulated caprylic acid successfully inhibited C. albicans growth at a lower concentration compared to caprylic acid. Overall, it was found that nano-encapsulated caprylic acid is a promising antifungal agent against Candida species; however, further studies are needed to be performed about nano-encapsulation of caprylic acid.
Article Type: Original Research |
Subject:
Mycology
Received: 2021/04/13 | Accepted: 2021/05/28 | Published: 2021/07/31
Received: 2021/04/13 | Accepted: 2021/05/28 | Published: 2021/07/31
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |